title: Optimer resurrects C. difficile antibiotic to win approval.
authors: Jeffrey L
authors: JL
authors: Fox
mesh_terms: D000617:Aminoglycosides / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy*; D017277:Drug Approval; D004345:Drug Industry / Q000639:trends*; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy*; D000077732:Fidaxomicin; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000077732:Fidaxomicin